Narula Sanjeev

Narula Sanjeev is listed in filings as Chief Financial & Bus. Officer at Phathom Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 2, 2026, including 9 public disclosures. Recent filings connect the profile to Phathom Pharmaceuticals, Inc. (PHAT) and Intra-Cellular Therapies Inc. (ITCI) (ITCI). The current snapshot covers public activity from Aug 14, 2024 to Jan 2, 2026. Reported amounts are shown as $673.1K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.